| 000 | 01179 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250513191752.0 | ||
| 264 | 0 | _c19991025 | |
| 008 | 199910s 0 0 eng d | ||
| 022 | _a1086-5802 | ||
| 024 | 7 |
_a10.1016/s1086-5802(16)30473-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLlana, M E | |
| 245 | 0 | 0 |
_aMethylphenidate: increased abuse or appropriate use? _h[electronic resource] |
| 260 |
_bJournal of the American Pharmaceutical Association (Washington, D.C. : 1996) _c |
||
| 300 |
_a526-30 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAttention Deficit Disorder with Hyperactivity _xdrug therapy |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aDrug Utilization |
| 650 | 0 | 4 | _aGuidelines as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMethylphenidate _xadverse effects |
| 650 | 0 | 4 |
_aSubstance-Related Disorders _xepidemiology |
| 700 | 1 | _aCrismon, M L | |
| 773 | 0 |
_tJournal of the American Pharmaceutical Association (Washington, D.C. : 1996) _gvol. 39 _gno. 4 _gp. 526-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s1086-5802(16)30473-9 _zAvailable from publisher's website |
| 999 |
_c10425339 _d10425339 |
||